ANGIOTECH PHARMACEUTICALS INC Deferred Tax Assets, Net of Valuation Allowance, Current
ANGIOTECH PHARMACEUTICALS INC had Deferred Tax Assets, Net of Valuation Allowance, Current of $5.88 million as of 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetCurrent · last filed 2013-03-28
- 2012-12-31: Deferred Tax Assets, Net of Valuation Allowance, Current $5.88M.
- 2012-09-30: Deferred Tax Assets, Net of Valuation Allowance, Current $4.93M.
- 2012-06-30: Deferred Tax Assets, Net of Valuation Allowance, Current $6.03M.
- 2012-03-31: Deferred Tax Assets, Net of Valuation Allowance, Current $4.29M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Current |
|---|---|
| 2012-12-31 | $5.88M 10-K · filed 2013-03-28 |
| 2012-09-30 | $4.93M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $6.03M 10-Q/A · filed 2012-09-13 |
| 2012-03-31 | $4.29M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $4.00M 10-K · filed 2013-03-28 |